2024-01-012024-12-312024-12-31false13004015LINK HEALTH GROUP LIMITED2025-12-30falseiso4217:GBPxbrli:pure130040152023-12-31130040152024-12-31130040152024-01-012024-12-31130040152022-12-31130040152023-12-31130040152023-01-012023-12-3113004015bus:SmallEntities2024-01-012024-12-3113004015bus:AuditExempt-NoAccountantsReport2024-01-012024-12-3113004015bus:FullAccounts2024-01-012024-12-3113004015bus:PrivateLimitedCompanyLtd2024-01-012024-12-3113004015core:WithinOneYear2024-12-3113004015core:AfterOneYear2024-12-3113004015core:WithinOneYear2023-12-3113004015core:AfterOneYear2023-12-3113004015core:ShareCapital2024-12-3113004015core:SharePremium2024-12-3113004015core:RevaluationReserve2024-12-3113004015core:OtherReservesSubtotal2024-12-3113004015core:RetainedEarningsAccumulatedLosses2024-12-3113004015core:ShareCapital2023-12-3113004015core:SharePremium2023-12-3113004015core:RevaluationReserve2023-12-3113004015core:OtherReservesSubtotal2023-12-3113004015core:RetainedEarningsAccumulatedLosses2023-12-3113004015core:LandBuildings2024-12-3113004015core:PlantMachinery2024-12-3113004015core:Vehicles2024-12-3113004015core:FurnitureFittings2024-12-3113004015core:OfficeEquipment2024-12-3113004015core:NetGoodwill2024-12-3113004015core:IntangibleAssetsOtherThanGoodwill2024-12-3113004015core:ListedExchangeTraded2024-12-3113004015core:UnlistedNon-exchangeTraded2024-12-3113004015core:LandBuildings2023-12-3113004015core:PlantMachinery2023-12-3113004015core:Vehicles2023-12-3113004015core:FurnitureFittings2023-12-3113004015core:OfficeEquipment2023-12-3113004015core:NetGoodwill2023-12-3113004015core:IntangibleAssetsOtherThanGoodwill2023-12-3113004015core:ListedExchangeTraded2023-12-3113004015core:UnlistedNon-exchangeTraded2023-12-3113004015core:LandBuildings2024-01-012024-12-3113004015core:PlantMachinery2024-01-012024-12-3113004015core:Vehicles2024-01-012024-12-3113004015core:FurnitureFittings2024-01-012024-12-3113004015core:OfficeEquipment2024-01-012024-12-3113004015core:NetGoodwill2024-01-012024-12-3113004015core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3113004015core:ListedExchangeTraded2024-01-012024-12-3113004015core:UnlistedNon-exchangeTraded2024-01-012024-12-3113004015core:MoreThanFiveYears2024-01-012024-12-3113004015core:Non-currentFinancialInstruments2024-12-3113004015core:Non-currentFinancialInstruments2023-12-3113004015dpl:CostSales2024-01-012024-12-3113004015dpl:DistributionCosts2024-01-012024-12-3113004015core:LandBuildings2024-01-012024-12-3113004015core:PlantMachinery2024-01-012024-12-3113004015core:Vehicles2024-01-012024-12-3113004015core:FurnitureFittings2024-01-012024-12-3113004015core:OfficeEquipment2024-01-012024-12-3113004015dpl:AdministrativeExpenses2024-01-012024-12-3113004015core:NetGoodwill2024-01-012024-12-3113004015core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3113004015dpl:GroupUndertakings2024-01-012024-12-3113004015dpl:ParticipatingInterests2024-01-012024-12-3113004015dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3113004015core:ListedExchangeTraded2024-01-012024-12-3113004015dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3113004015core:UnlistedNon-exchangeTraded2024-01-012024-12-3113004015dpl:CostSales2023-01-012023-12-3113004015dpl:DistributionCosts2023-01-012023-12-3113004015core:LandBuildings2023-01-012023-12-3113004015core:PlantMachinery2023-01-012023-12-3113004015core:Vehicles2023-01-012023-12-3113004015core:FurnitureFittings2023-01-012023-12-3113004015core:OfficeEquipment2023-01-012023-12-3113004015dpl:AdministrativeExpenses2023-01-012023-12-3113004015core:NetGoodwill2023-01-012023-12-3113004015core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3113004015dpl:GroupUndertakings2023-01-012023-12-3113004015dpl:ParticipatingInterests2023-01-012023-12-3113004015dpl:GroupUndertakingscore:ListedExchangeTraded2023-01-012023-12-3113004015core:ListedExchangeTraded2023-01-012023-12-3113004015dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-01-012023-12-3113004015core:UnlistedNon-exchangeTraded2023-01-012023-12-3113004015core:NetGoodwill2024-12-3113004015core:IntangibleAssetsOtherThanGoodwill2024-12-3113004015core:LandBuildings2024-12-3113004015core:PlantMachinery2024-12-3113004015core:Vehicles2024-12-3113004015core:FurnitureFittings2024-12-3113004015core:OfficeEquipment2024-12-3113004015core:AfterOneYear2024-12-3113004015core:WithinOneYear2024-12-3113004015core:ListedExchangeTraded2024-12-3113004015core:UnlistedNon-exchangeTraded2024-12-3113004015core:ShareCapital2024-12-3113004015core:SharePremium2024-12-3113004015core:RevaluationReserve2024-12-3113004015core:OtherReservesSubtotal2024-12-3113004015core:RetainedEarningsAccumulatedLosses2024-12-3113004015core:NetGoodwill2023-12-3113004015core:IntangibleAssetsOtherThanGoodwill2023-12-3113004015core:LandBuildings2023-12-3113004015core:PlantMachinery2023-12-3113004015core:Vehicles2023-12-3113004015core:FurnitureFittings2023-12-3113004015core:OfficeEquipment2023-12-3113004015core:AfterOneYear2023-12-3113004015core:WithinOneYear2023-12-3113004015core:ListedExchangeTraded2023-12-3113004015core:UnlistedNon-exchangeTraded2023-12-3113004015core:ShareCapital2023-12-3113004015core:SharePremium2023-12-3113004015core:RevaluationReserve2023-12-3113004015core:OtherReservesSubtotal2023-12-3113004015core:RetainedEarningsAccumulatedLosses2023-12-3113004015core:NetGoodwill2022-12-3113004015core:IntangibleAssetsOtherThanGoodwill2022-12-3113004015core:LandBuildings2022-12-3113004015core:PlantMachinery2022-12-3113004015core:Vehicles2022-12-3113004015core:FurnitureFittings2022-12-3113004015core:OfficeEquipment2022-12-3113004015core:AfterOneYear2022-12-3113004015core:WithinOneYear2022-12-3113004015core:ListedExchangeTraded2022-12-3113004015core:UnlistedNon-exchangeTraded2022-12-3113004015core:ShareCapital2022-12-3113004015core:SharePremium2022-12-3113004015core:RevaluationReserve2022-12-3113004015core:OtherReservesSubtotal2022-12-3113004015core:RetainedEarningsAccumulatedLosses2022-12-3113004015core:AfterOneYear2024-01-012024-12-3113004015core:WithinOneYear2024-01-012024-12-3113004015core:Non-currentFinancialInstrumentscore:CostValuation2024-01-012024-12-3113004015core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-012024-12-3113004015core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-012024-12-3113004015core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-012024-12-3113004015core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-012024-12-3113004015core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-012024-12-3113004015core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3113004015core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3113004015core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3113004015core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3113004015core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3113004015core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3113004015core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3113004015core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3113004015core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3113004015core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3113004015core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3113004015core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3113004015core:Non-currentFinancialInstrumentscore:CostValuation2023-12-3113004015core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-3113004015core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-3113004015core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-3113004015core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-3113004015core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-3113004015core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-3113004015core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-3113004015core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-3113004015bus:Director12024-01-012024-12-31

LINK HEALTH GROUP LIMITED

Registered Number
13004015
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2024

LINK HEALTH GROUP LIMITED
Company Information
for the year from 1 January 2024 to 31 December 2024

Director

GIBBS, Daniel

Registered Address

20 Market Sreet
Altrincham
WA14 1PF

Registered Number

13004015 (England and Wales)
LINK HEALTH GROUP LIMITED
Statement of Financial Position
31 December 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets31,5916,743
1,5916,743
Current assets
Debtors4179,187209,638
Cash at bank and on hand9,869100,331
189,056309,969
Creditors amounts falling due within one year5(180,127)(298,126)
Net current assets (liabilities)8,92911,843
Total assets less current liabilities10,52018,586
Net assets10,52018,586
Capital and reserves
Called up share capital100100
Profit and loss account10,42018,486
Shareholders' funds10,52018,586
The financial statements were approved and authorised for issue by the Director on 30 December 2025, and are signed on its behalf by:
GIBBS, Daniel
Director
Registered Company No. 13004015
LINK HEALTH GROUP LIMITED
Notes to the Financial Statements
for the year ended 31 December 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover consists of revenue earned from rendering of services.
Revenue from sale of goods
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Straight line (years)
Office Equipment3
2.Average number of employees

20242023
Average number of employees during the year2526
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 January 2415,98415,984
At 31 December 2415,98415,984
Depreciation and impairment
At 01 January 249,2419,241
Charge for year5,1525,152
At 31 December 2414,39314,393
Net book value
At 31 December 241,5911,591
At 31 December 236,7436,743
4.Debtors: amounts due within one year

2024

2023

££
Amounts owed by group undertakings156,173198,653
Other debtors20,2476,955
Prepayments and accrued income2,7674,030
Total179,187209,638
5.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables42,03628,923
Bank borrowings and overdrafts2,720-
Taxation and social security122,959255,951
Accrued liabilities and deferred income12,41213,252
Total180,127298,126
6.Related party transactions
During the year the company had the following transactions with companies in which the directors have a material interest. Brought forward: £198,653 Amount advanced: £2,230,217 Amount repaid: £2,272,697 Carried forward: £156,173 The loan above was repayable on demand and unsecured.